Vor Bio’s ADC therapy shows encouraging engraftment with reduced toxicity

November 10, 2023

FDA approves rare illness medication Xolremdi by X4

April 30, 2024

Lyell to pay $40M For Colorectal Cancer CAR-T Therapy

November 11, 2025

Must Read

GSK’s Hepatitis B Drug Gets FDA Green Light

October 22, 2026

Real-Time Commercial Intelligence in Life Sciences

October 22, 2026

Top 10 AI Skills Every Life Sciences Leader Needs

October 22, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Argenx Scraps Phase III Sjögren Study Over Predicted Efficacy Failure

Novo Launches Late-Stage Trial of Lower-Dose Wegovy Pill for Weight Management

Oregon Study Finds Triple-Drug Regimen Kept Infant Macaques HIV-Free for One Year

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

Disc Medicine’s Bitopertin Meets Phase 3 Goals in Rare Sunlight-Sensitivity Disorder

Vanda Puts Social Anxiety Program on Hold After Asset Fails Phase 3 Study

Tortugas Neuroscience Reports Positive Phase 2b Results for Schizophrenia Drug

BioNTech’s mRNA cancer vaccine fails phase 3 test

AstraZeneca Pens $1.5B Deal With Insitro Targeting Cardiometabolic Diseases

Merck to Acquire Silence Therapeutics for $1.3 Billion, Adding Experimental Blood Cancer Therapy

Roche Signs Huge Deal With Rona, Joins ALK7 Obesity Race

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Real-Time Commercial Intelligence in Life Sciences

Top 10 AI Skills Every Life Sciences Leader Needs

Digital Therapeutics 2.0: The Next Phase of Software-Based Treatment

Top 10 Advances in Protein Engineering

Manufacturing

Roche’s Actemra may see high demand and short supply due to COVID delta variant

Editor Picks

Vor Bio’s ADC therapy shows encouraging engraftment with reduced toxicity

FDA approves rare illness medication Xolremdi by X4

Lyell to pay $40M For Colorectal Cancer CAR-T Therapy

Must Read

GSK’s Hepatitis B Drug Gets FDA Green Light

Real-Time Commercial Intelligence in Life Sciences

Top 10 AI Skills Every Life Sciences Leader Needs

Hot Topics

About Us

Follow Us